Clonidine evokes vasodepressor responses via α2-adrenergic receptors in gigantocellular reticular formation

Sue Aicher, Carrie T. Drake

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The gigantocellular depressor area (GiDA) is a functionally defined subdivision of the medullary gigantocellular reticular formation where vasodepressor responses are evoked by glutamate nanoinjections. The GiDA also contains reticulospinal neurons that contain the α(2A)-adrenergic receptor (α(2A)-AR). In the present study, we sought to determine whether nanoinjections of the α2-AR agonist clonidine into the GiDA evoke cardiovascular responses and whether these responses can be attributed to the α2-AR. We found that nanoinjections of clonidine into the GiDA evoke dose- dependent decreases in arterial pressure and heart rate. These responses were equivalent in magnitude to responses produced by clonidine nanoinjections into the sympathoexcitatory region of the rostral ventrolateral medulla. Furthermore, the vasodepressor and bradycardic responses produced by clonidine injections into the GiDA were blocked in a dose-dependent fashion by the highly selective α2-AR antagonist 2-methoxyidazoxan, but not by prazosin, which is an antagonist at both the α1-AR and the 2B subtype of the α-AR. The antagonism by 2-methoxyidazoxan was site specific because injections of the antagonist into the rostral ventrolateral medulla failed to block the responses evoked by clonidine injections into the GiDA. These findings support the notion that clonidine produces sympathoinhibition through multiple sites within the medullary reticular formation, which is consistent with the wide distribution of the α(2A)-AR in reticulospinal neurons. These data also suggest that clonidine may have multiple mechanisms of action because it evokes a cardiovascular depressive response from regions containing neurons that have been determined to be both sympathoinhibitory and sympathoexcitatory.

Original languageEnglish (US)
Pages (from-to)688-694
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume289
Issue number2
StatePublished - May 1999
Externally publishedYes

Fingerprint

Reticular Formation
Clonidine
Adrenergic Receptors
Neurons
Injections
Prazosin
Glutamic Acid
Arterial Pressure
Heart Rate

ASJC Scopus subject areas

  • Pharmacology

Cite this

Clonidine evokes vasodepressor responses via α2-adrenergic receptors in gigantocellular reticular formation. / Aicher, Sue; Drake, Carrie T.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 289, No. 2, 05.1999, p. 688-694.

Research output: Contribution to journalArticle

@article{6ac425e7196f4c7692e3079143bd6f48,
title = "Clonidine evokes vasodepressor responses via α2-adrenergic receptors in gigantocellular reticular formation",
abstract = "The gigantocellular depressor area (GiDA) is a functionally defined subdivision of the medullary gigantocellular reticular formation where vasodepressor responses are evoked by glutamate nanoinjections. The GiDA also contains reticulospinal neurons that contain the α(2A)-adrenergic receptor (α(2A)-AR). In the present study, we sought to determine whether nanoinjections of the α2-AR agonist clonidine into the GiDA evoke cardiovascular responses and whether these responses can be attributed to the α2-AR. We found that nanoinjections of clonidine into the GiDA evoke dose- dependent decreases in arterial pressure and heart rate. These responses were equivalent in magnitude to responses produced by clonidine nanoinjections into the sympathoexcitatory region of the rostral ventrolateral medulla. Furthermore, the vasodepressor and bradycardic responses produced by clonidine injections into the GiDA were blocked in a dose-dependent fashion by the highly selective α2-AR antagonist 2-methoxyidazoxan, but not by prazosin, which is an antagonist at both the α1-AR and the 2B subtype of the α-AR. The antagonism by 2-methoxyidazoxan was site specific because injections of the antagonist into the rostral ventrolateral medulla failed to block the responses evoked by clonidine injections into the GiDA. These findings support the notion that clonidine produces sympathoinhibition through multiple sites within the medullary reticular formation, which is consistent with the wide distribution of the α(2A)-AR in reticulospinal neurons. These data also suggest that clonidine may have multiple mechanisms of action because it evokes a cardiovascular depressive response from regions containing neurons that have been determined to be both sympathoinhibitory and sympathoexcitatory.",
author = "Sue Aicher and Drake, {Carrie T.}",
year = "1999",
month = "5",
language = "English (US)",
volume = "289",
pages = "688--694",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Clonidine evokes vasodepressor responses via α2-adrenergic receptors in gigantocellular reticular formation

AU - Aicher, Sue

AU - Drake, Carrie T.

PY - 1999/5

Y1 - 1999/5

N2 - The gigantocellular depressor area (GiDA) is a functionally defined subdivision of the medullary gigantocellular reticular formation where vasodepressor responses are evoked by glutamate nanoinjections. The GiDA also contains reticulospinal neurons that contain the α(2A)-adrenergic receptor (α(2A)-AR). In the present study, we sought to determine whether nanoinjections of the α2-AR agonist clonidine into the GiDA evoke cardiovascular responses and whether these responses can be attributed to the α2-AR. We found that nanoinjections of clonidine into the GiDA evoke dose- dependent decreases in arterial pressure and heart rate. These responses were equivalent in magnitude to responses produced by clonidine nanoinjections into the sympathoexcitatory region of the rostral ventrolateral medulla. Furthermore, the vasodepressor and bradycardic responses produced by clonidine injections into the GiDA were blocked in a dose-dependent fashion by the highly selective α2-AR antagonist 2-methoxyidazoxan, but not by prazosin, which is an antagonist at both the α1-AR and the 2B subtype of the α-AR. The antagonism by 2-methoxyidazoxan was site specific because injections of the antagonist into the rostral ventrolateral medulla failed to block the responses evoked by clonidine injections into the GiDA. These findings support the notion that clonidine produces sympathoinhibition through multiple sites within the medullary reticular formation, which is consistent with the wide distribution of the α(2A)-AR in reticulospinal neurons. These data also suggest that clonidine may have multiple mechanisms of action because it evokes a cardiovascular depressive response from regions containing neurons that have been determined to be both sympathoinhibitory and sympathoexcitatory.

AB - The gigantocellular depressor area (GiDA) is a functionally defined subdivision of the medullary gigantocellular reticular formation where vasodepressor responses are evoked by glutamate nanoinjections. The GiDA also contains reticulospinal neurons that contain the α(2A)-adrenergic receptor (α(2A)-AR). In the present study, we sought to determine whether nanoinjections of the α2-AR agonist clonidine into the GiDA evoke cardiovascular responses and whether these responses can be attributed to the α2-AR. We found that nanoinjections of clonidine into the GiDA evoke dose- dependent decreases in arterial pressure and heart rate. These responses were equivalent in magnitude to responses produced by clonidine nanoinjections into the sympathoexcitatory region of the rostral ventrolateral medulla. Furthermore, the vasodepressor and bradycardic responses produced by clonidine injections into the GiDA were blocked in a dose-dependent fashion by the highly selective α2-AR antagonist 2-methoxyidazoxan, but not by prazosin, which is an antagonist at both the α1-AR and the 2B subtype of the α-AR. The antagonism by 2-methoxyidazoxan was site specific because injections of the antagonist into the rostral ventrolateral medulla failed to block the responses evoked by clonidine injections into the GiDA. These findings support the notion that clonidine produces sympathoinhibition through multiple sites within the medullary reticular formation, which is consistent with the wide distribution of the α(2A)-AR in reticulospinal neurons. These data also suggest that clonidine may have multiple mechanisms of action because it evokes a cardiovascular depressive response from regions containing neurons that have been determined to be both sympathoinhibitory and sympathoexcitatory.

UR - http://www.scopus.com/inward/record.url?scp=0032902556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032902556&partnerID=8YFLogxK

M3 - Article

C2 - 10215641

AN - SCOPUS:0032902556

VL - 289

SP - 688

EP - 694

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -